Magda Ali
Canny CLO managers have diversified into other credit instruments so as to avoid becoming a hostage to unfavourable market conditions, whilst a brave few are starting to raise new vehicles. But that still leaves a big hole in European liquidity once the previous generation of funds reach the end of their reinvestment periods. Magda Ali reports.
.jpg "ICG nears €400m CLO close")
The London-listed asset manager hopes to conclude fundraising for its latest CLO by the end of June.
.JPG "Hercules Tech backs biopharmaceutical with $30m")
The biotechnology finance firm has provided a three-tranche $45m term loan to drug developer Anacor Pharmaceuticals.
The frontier Asia and Sub-Saharan Africa specialist private equity firm has provided a term loan to Zimbabwean bank NMB Bank.
.jpg "LPs boost allocation to private debt")
A third of LPs surveyed in Coller Capital’s latest ‘barometer’ plan to increase their allocations to credit investments, whilst half already have or plan to have exposure to private debt funds.
Avebury Capital has steadily expanded its private placement and advisory debt unit in the past year; securing contracts with likes of ICG and Prefequity. James Newsome, managing partner at the firm shares some lessons learnt on the road.
.jpg "S&P warns of $3.9trn European refinancing challenge")
The rating agency raised concerns about the ability of European lenders to meet corporate funding needs as they deal with the impact of sluggish economic growth.
.jpg "Saas Capital backs Monet Software")
The software-specialist debt fund manager has made its fifth allocation from its first debt fund.
The Chicago-based debt fund manager has closed its third transaction with a portfolio company of Freeman Spogli.
/June/News/insulin80.jpg "Capital Royalty backs Valeritas with $100m")
The healthcare-focused debt fund manager has provider a term loan to insulin device manufacturer Valeritas.